Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)

Clinical trial NCT04345601 · COMPLETED

Trial details

NCT number: NCT04345601
Sponsor: Baylor College of Medicine
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sars-CoV2 Acute Respiratory Distress Syndrome COVID-19

Start date: 2021-02-12
Primary completion: 2023-01-10
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.